» Articles » PMID: 3508523

N-(2-cyanoethyl)tranylcypromine, a Potential Prodrug of Tranylcypromine: Its Disposition and Interaction with Catecholamine Neurotransmitters in Brain

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1987 Feb 1
PMID 3508523
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The disposition of the N-cyanoethyl analogue of tranylcypromine (TCP) and the TCP formed from it have been studied in the rat brain following intraperitoneal (ip) administration (0.1 mmol/kg) and the resultant data compared with those obtained following an equimolar dose of TCP. Brain concentrations of the neurotransmitter amines dopamine (DA) and noradrenaline (NA) have also been determined, as well as the percentage inhibition of monoamine oxidase (MAO) types A and B. Our results indicate that the N-cyanoethyl analogue may be a useful prodrug of TCP, providing lower but more sustained concentrations of TCP in brain. Brain levels of DA were increased in a similar pattern after CE-TCP or TCP. Brain levels of NA were decreased by TCP at most time intervals, while CE-TCP produced a much less pronounced effect. Both CE-TCP and TCP inhibited MAO-A and MAO-B, with maximum inhibition occurring 60 min after CE-TCP dosing and 30 min after dosing with TCP, times at which brain concentrations of CE-TCP and TCP were at the maximum.

Citing Articles

Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake.

Weber M, Talmon S, Schulze I, Boeddinghaus C, Gross G, Schoemaker H Psychopharmacology (Berl). 2008; 203(4):753-62.

PMID: 19104776 DOI: 10.1007/s00213-008-1420-4.


Pharmacokinetic and neurochemical studies on N-propargyl-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Rao T, Baker G, Coutts R Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(1):25-32.

PMID: 3627289 DOI: 10.1007/BF00177747.


Para-hydroxytranylcypromine: presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue.

Nazarali A, Baker G, Coutts R, Greenshaw A Eur J Drug Metab Pharmacokinet. 1987; 12(3):207-14.

PMID: 3436344 DOI: 10.1007/BF03189899.


Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Baker G, Coutts R, Rao T Br J Pharmacol. 1987; 92(2):243-55.

PMID: 2890391 PMC: 1853650. DOI: 10.1111/j.1476-5381.1987.tb11318.x.


"Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.

Martin-Iverson M, Yamada N, By A, Lodge B J Psychiatry Neurosci. 1991; 16(5):253-61.

PMID: 1686728 PMC: 1188362.

References
1.
Kim C, Campanelli C, Khanna J . Determination of picogram levels of brain catecholamines and indoles by a simplified liquid chromatographic electrochemical detection method. J Chromatogr. 1983; 282:151-9. DOI: 10.1016/s0021-9673(00)91599-1. View

2.
Wurtman R, Axelrod J . A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE. Biochem Pharmacol. 1963; 12:1439-41. DOI: 10.1016/0006-2952(63)90215-6. View

3.
Hertel G . [Treatment of obese female patients with fenproporex within the framework of gynecologic practice]. Fortschr Med. 1978; 96(47-48):2380-2. View

4.
Calverley D, Baker G, Coutts R, Dewhurst W . A method for measurement of tranylcypromine in rat brain regions using gas chromatography with electron capture detection. Biochem Pharmacol. 1981; 30(8):861-7. DOI: 10.1016/s0006-2952(81)80008-1. View

5.
BECKETT A, Shenoy E, Salmon J . The influence of replacement of the N-ethyl group by the cyanoethyl group on the absorption, distribution and metabolism of (plus or minus)-ethylamphetamine in man. J Pharm Pharmacol. 1972; 24(3):194-202. DOI: 10.1111/j.2042-7158.1972.tb08964.x. View